May 19, 2020
A key health ministry advisory committee will discuss on May 29 whether to approve the hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors from GlaxoSmithKline and Mitsubishi Tanabe Pharma - daprodustat and vadadustat. They are expected to receive official approval in June...read more